Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Br J Anaesth. 2020 Mar;124(3):251-260. doi: 10.1016/j.bja.2019.11.034. Epub 2020 Jan 29.
Immunotherapy has revolutionised the treatment of oncologic malignancies. Immune checkpoint inhibitors represent a new class of immunotherapy drugs. Although these drugs show promise, they are associated with immune-related adverse reactions. An increasing number of patients who undergo surgery will have had treatment with immune checkpoint inhibitors. In this narrative review article, we discuss their mechanism of action, therapeutic effects, pertinent toxicities, and address specific perioperative considerations for patients treated with immune checkpoint inhibitors.
免疫疗法已经彻底改变了肿瘤学恶性肿瘤的治疗方法。免疫检查点抑制剂代表了一类新的免疫治疗药物。虽然这些药物显示出了前景，但它们与免疫相关的不良反应有关。越来越多接受手术的患者曾接受过免疫检查点抑制剂治疗。在这篇叙述性综述文章中，我们讨论了它们的作用机制、治疗效果、相关毒性，并针对接受免疫检查点抑制剂治疗的患者提出了具体的围手术期注意事项。
